Global Gene Expression Analysis Market Report (2022 to 2027) - Industry Trends, Share, Size, Growth, Opportunity and Forecasts


Dublin, Sept. 27, 2022 (GLOBE NEWSWIRE) -- The "Gene Expression Analysis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.

The global gene expression analysis market size reached US$ 4.2 Billion in 2021. Looking forward, the publisher expects the market to reach US$ 7.8 Billion by 2027, exhibiting a CAGR of 10.87% during 2021-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Gene expression analysis (GEA) is the method of extracting data from a gene to investigate the behaviour of biological systems. It involves different processes such as gene transcription, translation, post-translational modification of protein and RNA splicing. The data obtained from this analysis is used for the production of proteins, Ribonucleic Acid (RNA) and various microbiological products.

They are further utilized for the development of new drugs and improving the existing diagnostic methods. GEA is now widely considered to be essential in explaining the mechanisms that cause numerous medical ailments, owing to which it finds extensive applications in pharmacogenomics, biomarking, toxicology and diagnostics.

The increasing adoption of targeted molecular therapeutics, along with the growing demand for personalized medicines, is among the key factors driving the growth of the market. GEA has proven to be a powerful tool in molecular biology studies, which are used to understand the functioning of genes, diagnose ailments and facilitate drug development. Furthermore, the growing prevalence of chronic diseases, such as cancer, tuberculosis, and cardiovascular and genetic disorders is providing a significant boost to the market growth.

Additionally, the development of personalized medicines to cure these ailments has enabled the modifications of diagnostic and treatment methods according to the individual patient requirement. Moreover, various technological advancements, such as the advent of Next Generation Sequencing (NGS), along with the development of genomic databases, higher success rates of GEA and enhanced focus on research and development (R&D) in gene therapy, are further projected to drive the market growth.

Competitive Landscape:

The competitive landscape of the industry has also been examined with some of the key players being Agilent Technologies, Inc., BGI Genomics Co., Ltd., Bio-Rad Laboratories, Inc., Eurofins GSC Lux SARL, F. Hoffmann-La Roche Ltd, GE Healthcare, Illumina, Inc., Oxford Gene Technology IP Limited, Pacific Biosciences of California Inc., PerkinElmer Inc., QIAGEN GmbH, and Thermo Fisher Scientific Inc., etc.

Key Questions Answered in This Report:

  • How has the global gene expression analysis market performed so far and how will it perform in the coming years?
  • What are the key regional markets?
  • What has been the impact of COVID-19 on the global gene expression analysis market?
  • What is the breakup of the market based on the products & services?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the capacity?
  • What is the breakup of the market based on the end-user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the market?
  • What is the structure of the global gene expression analysis market and who are the key players?
  • What is the degree of competition in the market?

Key Topics Covered:

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction
4.1 Overview
4.2 Key Industry Trends

5 Global Gene Expression Analysis Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact Of COVID-19
5.4 Market Forecast

6 Market Breakup by Products & Services
6.1 Consumables
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Instruments
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Services
6.3.1 Market Trends
6.3.2 Market Forecast

7 Market Breakup by Technology
7.1 Polymerase Chain Reaction (PCR)
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Next Generation Sequencing (NGS)
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 DNA Microarray
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Sanger Sequencing
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast

8 Market Breakup by Capacity
8.1 Low-to Mid-Plex Gene Expression Analysis
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 High-Plex Gene Expression Analysis
8.2.1 Market Trends
8.2.2 Market Forecast

9 Market Breakup by End-User
9.1 Pharmaceutical and Biotech Companies
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Academic Institutes and Research Centers
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Others
9.3.1 Market Trends
9.3.2 Market Forecast

10 Market Breakup by Region

11 SWOT Analysis

12 Value Chain Analysis

13 Porters Five Forces Analysis

14 Price Indicators

15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Agilent Technologies, Inc.
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 BGI Genomics Co., Ltd.
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.3 Bio-Rad Laboratories, Inc.
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.3.4 SWOT Analysis
15.3.4 Eurofins GSC Lux SARL
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.5 F. Hoffmann-La Roche Ltd
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 Financials
15.3.6 GE Healthcare
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.7 Illumina, Inc.
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.7.4 SWOT Analysis
15.3.8 Oxford Gene Technology IP Limited
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.9 Pacific Biosciences of California Inc.
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.10 PerkinElmer Inc.
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.10.4 SWOT Analysis
15.3.11 QIAGEN GmbH
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials
15.3.12 Thermo Fisher Scientific Inc.
15.3.12.1 Company Overview
15.3.12.2 Product Portfolio
15.3.12.3 Financials
15.3.12.4 SWOT Analysis

For more information about this report visit https://www.researchandmarkets.com/r/c5ecbf

Attachment

 
Global Gene Expression Analysis Market

Contact Data